- Research Progress on the Effects of FXR on the Development of Colorectal Cancer
奕岑 钱, 2024, Hans Journal of Biomedicine CrossRef - Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
Mengjiao Zhou et al, 2022, Frontiers in Pharmacology CrossRef - Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer
Sosmitha Girisa et al, 2021, Molecular Biomedicine CrossRef